Back

Choose your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia-Herzegovina Bosnia-Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Germany Germany Flag Hungary Hungary Flag Italy Italy Flag Kosovo Kosovo Flag Latvia Latvia Flag Lithuania Lithuania Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Montenegro Montenegro Flag Poland Poland (Lab) Flag Portugal Portugal (Lab) Flag Romania Romania (Lab) Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Spain Spain (Lab) Flag Switzerland Switzerland (Lab) Flag Sweden Sweden Flag Turkey Turkey (Lab) Flag United Kingdom United Kingdom

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
801 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 41
802 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 70
803 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 57
804 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 70
805 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 47
806 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 29
807 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 66
808 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 68
809 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 40
810 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 56
811 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 69
812 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 59
813 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 56
814 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 68
815 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 66
816 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 63
817 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 64
818 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 64
819 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 63
820 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 65
821 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 68
822 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 44
823 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 66
824 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 48
825 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 45
826 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 67
827 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 69
828 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 72
829 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 53
830 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 71
831 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 66
832 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 57
833 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 74
834 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2023 Standard Therapy Poland 72
835 Apheresis Allogeneic Myelodysplastic Syndrome Lb High Risk Hematology 2023 Standard Therapy Poland 58
836 Apheresis Allogeneic Myelodysplastic Syndrome With Multilineage Dysplasia Hematology 2023 Standard Therapy Poland 68
837 Apheresis Allogeneic Myelodysplastic Syndrome/Acute Myelogenous Leukemia Hematology 2023 Standard Therapy Poland 42
838 Apheresis Allogeneic Myelodysplastic Syndrome-Eb1 Hematology 2023 Standard Therapy Poland 48
839 Apheresis Allogeneic Myelodysplastic Syndromes (Mds) Hematology 2023 Standard Therapy Poland 73
840 Apheresis Allogeneic Myelodysplastic Syndromes (Mds) Hematology 2023 Standard Therapy Poland 76
841 Apheresis Allogeneic Myelodysplastic Syndromes (Mds) Hematology 2023 Standard Therapy Poland 70
842 Apheresis Allogeneic Myelodysplastic Syndromes (Mds) Hematology 2023 Standard Therapy Poland 5
843 Apheresis Allogeneic Myelofibrosis Hematology 2023 Standard Therapy Poland 65
844 Apheresis Allogeneic Myelofibrosis Hematology 2023 Standard Therapy Poland 56
845 Apheresis Allogeneic Myelofibrosis Hematology 2023 Standard Therapy Poland 70
846 Apheresis Allogeneic Myelofibrosis Hematology 2023 Standard Therapy Poland 69
847 Apheresis Allogeneic Myelofibrosis Hematology 2023 Standard Therapy Poland 61
848 Apheresis Allogeneic Myelofibrosis Hematology 2023 Standard Therapy Poland 70
849 Apheresis Allogeneic Myelofibrosis Hematology 2023 Standard Therapy Poland 68
850 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2023 Standard Therapy Poland 50
851 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2023 Standard Therapy Poland 54
852 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2023 Standard Therapy Poland 60
853 Apheresis Allogeneic Myeloma Multiplex Hematology 2023 Standard Therapy Poland 63
854 Apheresis Autologous No Data Hematology 2023 Standard Therapy Germany 69
855 Apheresis Autologous No Data Hematology 2023 Standard Therapy Germany 53
856 Apheresis Allogeneic No Data Hematology 2023 Standard Therapy Poland 50
857 Apheresis Allogeneic No Data Hematology 2023 Standard Therapy Poland 23
858 Apheresis Allogeneic No Data Hematology 2023 Standard Therapy Poland 39
859 Apheresis Allogeneic No Data Hematology 2023 Standard Therapy Poland 2
860 Apheresis Allogeneic No Data Hematology 2023 Standard Therapy Poland 52
861 Apheresis Allogeneic No Data Hematology 2023 Standard Therapy Poland 61
862 Apheresis Autologous No Data Hematology 2023 Standard Therapy Germany 60
863 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2023 Standard Therapy Poland 71
864 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2023 Standard Therapy Poland 44
865 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2023 Standard Therapy Poland 72
866 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2023 Standard Therapy Poland 66
867 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2023 Standard Therapy Poland 33
868 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2023 Standard Therapy Poland 42
869 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2023 Standard Therapy Poland 63
870 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2023 Standard Therapy Poland 19
871 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2023 Standard Therapy Poland 54
872 Apheresis Autologous Nonseminoma, Relapse Hematology 2023 Standard Therapy Germany 48
873 Apheresis Allogeneic Orofacial Myofunctional Disorders (Omds), Primary Myelofibrosis (Pmf) Hematology 2023 Standard Therapy Poland 69
874 Apheresis Allogeneic Osteomyelofibrosis Hematology 2023 Standard Therapy Poland 60
875 Apheresis Allogeneic Other Immune System Hematology 2023 Standard Therapy Poland 71
876 Apheresis Allogeneic Other Malignancy Hematology 2023 Standard Therapy Poland 49
877 Apheresis Allogeneic Other Myelofibrosis Hematology 2023 Standard Therapy Poland 56
878 Apheresis Allogeneic Other Non-Malignant Disease Hematology 2023 Standard Therapy Poland 70
879 Apheresis Allogeneic Paroxysmal Nocturnal Hemoglobinuria (Pnh) Hematology 2023 Standard Therapy Poland 36
880 Apheresis Allogeneic Peripheral T-Cell Lymphoma Hematology 2023 Standard Therapy Poland 47
881 Apheresis Autologous Plasma Cell Leukemia Hematology 2023 Standard Therapy Germany 70
882 Apheresis Autologous Plasma Cell Leukemia Hematology 2023 Standard Therapy Germany 56
883 Apheresis Autologous Plasmacytoma Hematology 2023 Standard Therapy Germany 63
884 Apheresis Allogeneic Post Therapeutic Myelodysplastic Syndrome /Acute Myelogenous Leukemia After Chronic Lymphocytic Leukemia Hematology 2023 Standard Therapy Poland 60
885 Apheresis Allogeneic Post–Polycythemia Vera Myelofibrosis Hematology 2023 Standard Therapy Poland 38
886 Apheresis Allogeneic Pra B-Cell Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 20
887 Apheresis Allogeneic Pre-B-Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 41
888 Apheresis Allogeneic Pre-B-Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 61
889 Apheresis Allogeneic Pre-B-Acute Myelogenous Leukemia Hematology 2023 Standard Therapy Poland 11
890 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2023 Standard Therapy Germany 63
891 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2023 Standard Therapy Germany 73
892 Apheresis Allogeneic Primary Myelofibrosis Hematology 2023 Standard Therapy Germany 70
893 Apheresis Allogeneic Primary Myelofibrosis Hematology 2023 Standard Therapy Poland 68
894 Apheresis Allogeneic Primary Myelofibrosis Hematology 2023 Standard Therapy Poland 68
895 Apheresis Allogeneic Primary Myelofibrosis Hematology 2023 Standard Therapy Poland 31
896 Apheresis Allogeneic Primary Myelofibrosis Hematology 2023 Standard Therapy Poland 63
897 Apheresis Allogeneic Primary Myelofibrosis Hematology 2023 Standard Therapy Germany 46
898 Apheresis Allogeneic Primary Myelofibrosis Hematology 2023 Standard Therapy Poland 68
899 Apheresis Allogeneic Relapsed B-Cell Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 11
900 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 55